|
ABT
|
Abbott Laboratories
|
US
|
NYSE
|
|
ACRX
|
AcelRx Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
US
|
NASDAQ
|
|
ARTL
|
Artelo Biosciences, Inc.
|
US
|
NASDAQ
|
|
ASRT
|
Assertio Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ATNF
|
180 Life Sciences Corp.
|
US
|
NASDAQ
|
|
AVXL
|
Anavex Life Sciences Corp.
|
US
|
NASDAQ
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
US
|
NASDAQ
|
|
BIOL
|
Biolase, Inc.
|
US
|
NASDAQ
|
|
BLRX
|
BioLineRx Ltd.
|
US
|
NASDAQ
|
|
BNTC
|
Benitec Biopharma Limited
|
US
|
NASDAQ
|
|
CARA
|
Cara Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CCM
|
Concord Medical Services Holdings Limited ADS
|
US
|
NYSE
|
|
CNCE
|
Concert Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
COLL
|
Collegium Pharmaceutical, Inc.
|
US
|
NASDAQ
|
|
CPIX
|
Cumberland Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
DRRX
|
DURECT Corporation
|
US
|
NASDAQ
|
|
DRUG
|
Bright Minds Biosciences Inc.
|
US
|
NASDAQ
|
|
EHAB
|
Enhabit, Inc.
|
US
|
NYSE
|